Fractures, Bone
1
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Zimmer BiometFL - Jacksonville
1 programBiomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.N/A1 trial
Active Trials
Human BioSciencesWV - Martinsburg
1 programBlood draws to assess RNA expression levelsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Human BioSciencesBlood draws to assess RNA expression levels
Zimmer BiometBiomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
BioretecBiodegradable Intramedullary Nailing
GSKTZD only
Clinical Trials (4)
Total enrollment: 98,659 patients across 4 trials
855303-RNA Biomarker Validation
Start: Aug 2025Est. completion: Aug 2028110 patients
N/AEnrolling By Invitation
MDR - Biomet Cannulated Screws
Start: Aug 2019Est. completion: Dec 202651 patients
N/AActive Not Recruiting
Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing
Start: Jan 2019Est. completion: Jan 202315 patients
N/ACompleted
Fracture Risk With Thiazolidinediones
Start: May 2009Est. completion: Mar 201098,483 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.